Jane Street’s Applied Therapeutics APLT Stock Holding History

Jane Street’s Portfolio APLT Stock Details APLT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-50,800	Closed	-$30.7K	–	11039
2025 Q3	$30.7K	Buy	50,800 +28,400	+127%	+$13.4K	﹤0.01%	10454
2025 Q2	$6.97K	Buy	+22,400	New	+$8.67K	﹤0.01%	9423
2025 Q1	–	Sell	-130,300	Closed	-$112K	–	9363
2024 Q4	$112K	Buy	130,300 +77,500	+147%	+$486K	﹤0.01%	8723
2024 Q3	$449K	Sell	52,800 -17,700	-25%	-$104K	﹤0.01%	7372
2024 Q2	$329K	Sell	70,500 -183,200	-72%	-$867K	﹤0.01%	7665
2024 Q1	$1.73M	Buy	+253,700	New	+$1.14M	﹤0.01%	4392

Jane Street's APLT Position: Q1 2026 in Review

Jane Street sold out of Applied Therapeutics (APLT) in Q1 2026, closing a stake of 2,087,404 shares — an estimated $209K sold.

Jane Street first reported a position in APLT in Q4 2022 and held it in 8 quarters. The position peaked at $1.66M in Q1 2024. 0 funds tracked by Wall St. Rank hold APLT as of Q1 2026.

Jane Street reported no remaining Applied Therapeutics position as of Q1 2026 after selling out during the quarter.
Jane Street sold 2,087,404 Applied Therapeutics shares in Q1 2026, an estimated $209K.
Jane Street first reported a position in Applied Therapeutics in Q4 2022 and held it in 8 quarters.
Jane Street's Applied Therapeutics position peaked at $1.66M in Q1 2024.
0 funds tracked by Wall St. Rank held Applied Therapeutics as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.